Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients.
about
A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixturesPortal Vein Embolization as an Oncosurgical Strategy Prior to Major Hepatic Resection: Anatomic, Surgical, and Technical ConsiderationsPortal vein embolization: rationale, technique, and current application.Safety and efficacy of preoperative right portal vein embolization in patients at risk for postoperative liver failure following major right hepatectomy.Complications of Portal Vein Embolization: Evaluation on Cross-Sectional Imaging.Transsinusoidal portal vein embolization with ethylene vinyl alcohol copolymer (Onyx): a feasibility study in pigsPortal vein embolization before liver resection: a systematic reviewFeasibility of laparoscopic portal vein ligation prior to major hepatectomyImpaired liver function attenuates liver regeneration and hypertrophy after portal vein embolization.Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization.Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.Interventional oncology: new options for interstitial treatments and intravascular approaches: right hepatic vein embolization after right portal vein embolization for inducing hypertrophy of the future liver remnant.Quality improvement for portal vein embolization.Portal vein embolization: rationale, outcomes, controversies and future directions.Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.Current treatment for colorectal liver metastasesPortal vein embolization: what do we know?Portal vein embolization and ligation for extended hepatectomyPortal vein embolization in extended liver resection.Acute Thrombosis of Left Portal Vein during Right Portal Vein Embolization Extended to Segment 4.Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions.Preoperative portal venous and hepatic arterial embolization of tumorIndications for portal vein embolization in perihilar cholangiocarcinoma.Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization.Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils.Portal vein embolization using a Histoacryl/Lipiodol mixture before right liver resection.Portal vein embolization induces compensatory hypertrophy of remnant liverFoam sclerotherapy using polidocanol (aethoxysklerol) for preoperative portal vein embolization in 16 patients.Liver hypertrophy after percutaneous portal vein embolization: comparison of N-butyl-2-cyanocrylate versus sodium acrylate-vinyl alcohol copolymer particles in a swine model.Hypertrophy of the non-embolized liver after chemotherapy.Sequential arterial and portal vein embolization in patients with cirrhosis and hepatocellular carcinoma: the hospital beaujon experience.Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes.Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma.Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?Portal vein embolization with n-butyl-cyanoacrylate through an ipsilateral approach before major hepatectomy: single center analysis of 50 consecutive patients.Portal vein embolisation for extended hepatectomy: single-centre experience.Infusion of 50% glucose solution to occlude an intrahepatic portosystemic venous shunt before percutaneous transhepatic portal embolization: report of a case.Portal Vein Embolization: State-of-the-Art Technique and Options to Improve Liver Hypertrophy.C-Arm Cone Beam CT for Intraprocedural Image Fusion and 3D Guidance in Portal Vein Embolization (PVE).N-butyl-2 cyanoacrylate (NBCA) embolus in the graft portal vein after portosystemic collateral embolization in liver transplantation recipient: what is the clinical significance?
P2860
Q25257114-467E8066-585B-489A-B2F4-87A0E6083720Q26750812-0D22179B-1786-480E-91E9-0D6E5CC8B6FAQ34652519-0C1BBDE6-01D8-47A3-8A1D-1463CCECCB83Q35657987-670CF9DA-5B9A-4797-8DA6-82CE77B79BACQ36026842-633D5793-EBC4-41AD-93E7-27EB58002FF2Q36247755-38F7B1D4-D650-4617-856F-C146C37138FDQ36546055-5EDEEF6C-F47E-4B5F-9EC6-8D0B44BC10F2Q37275505-3D281CE5-64FA-4A51-8601-1A538B36D2C7Q37321973-C5CDB813-156B-40AA-AC71-31B7C89689B9Q37413297-066A0CAC-2E48-497A-8B28-01E23D45FEA5Q37478218-5AE8ACFE-E776-48FD-8AF7-332DE72AE289Q37627654-62C7C100-AEDE-46FB-B506-5C3BCD52DF6BQ37687163-F25F5365-F6C6-4861-8E7D-248B15F412C2Q37777157-80D08AB2-6B4F-4CD4-93CA-A68B54765438Q37907117-0F7C1A9A-C0EC-450C-8E49-D829DFA846D2Q37951004-42EA8942-CD9E-4075-A8D2-6E7D704DB59DQ37968916-7327141B-F52C-40D4-877D-6A793172CA34Q38199484-31AB9A48-DC59-4B22-B6F5-4A0CF8F996D6Q38676385-7022134D-C53B-49C2-987B-05931E5FC61EQ38704922-F384BDB6-8688-4F41-B0FC-19FA2802E0D1Q38762480-48530079-2C60-48EF-9F01-83A0AB746415Q39210533-EA1A6A49-1BCF-4D97-BF7F-D7D916DE285FQ39251784-803C988D-88FA-4F61-89CB-C3E3F836A053Q39310997-38E3709D-E80F-4223-BEE8-9E794F1E1758Q39476816-D03D73AC-8369-47E7-800F-AC3735C1FFACQ39585934-FFB55563-1BD2-4D07-B8A1-3E381F0E2FB1Q39746271-87BF3046-427C-4BF3-BE11-F92EA9000C79Q39786988-D77FDC3E-3AE6-4259-8CC2-89AA0CEFA1D0Q39813488-418AC640-444F-46D3-99ED-21787EC69F55Q39964155-F664F47D-EF2C-408B-9DB2-FB44A7F287F7Q40086232-8164BC83-E075-41F8-BEBF-B39B3B3D5001Q40086240-DFB81B06-742F-40EB-8DC3-5AB8DE4477C1Q40086254-32DDF214-837A-4030-8592-E1465C757B0EQ40183748-C13722E6-5814-4B4F-A20F-685FF41BD02CQ41695876-90688ED4-2C81-46F1-A007-A349B367BF8CQ43703861-38D4D9D1-B8F4-417D-A311-B57DFB016705Q45862114-61A6FCFF-A2BE-4CA1-ACBE-C2CCD8CF5726Q47726281-0083BAB9-08DE-418F-B003-179EEF9571DCQ47963679-89CFB9EE-29C7-405E-AE23-600E97A9DCBAQ50969803-762ABC6A-77D0-4987-AFAA-C9631B0AD78A
P2860
Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Preoperative percutaneous port ...... dverse events in 188 patients.
@ast
Preoperative percutaneous port ...... dverse events in 188 patients.
@en
type
label
Preoperative percutaneous port ...... dverse events in 188 patients.
@ast
Preoperative percutaneous port ...... dverse events in 188 patients.
@en
prefLabel
Preoperative percutaneous port ...... dverse events in 188 patients.
@ast
Preoperative percutaneous port ...... dverse events in 188 patients.
@en
P2093
P1433
P1476
Preoperative percutaneous port ...... dverse events in 188 patients.
@en
P2093
Alban Denys
Antoine Hakime
Dominique Elias
Donatella R Di Stefano
Gilles Gorin
Hervé Trillaud
Jean Saric
Jean-Michel Bartoli
Jean-Robert Delpero
Michel Gillet
P304
P356
10.1148/RADIOL.2342031996
P407
P577
2004-12-10T00:00:00Z